Filter
13
Text search:
The
Montpellier
Panel
Featured
Recommendations
3
New Publications
2
Language
Document type
No document type
7
Studies & Reports
2
Guidelines
2
Strategic & Response Plan
2
Countries / Regions
Global
2
Africa
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
6
Women & Child Health
3
Public Health
2
Key Resources
1
Toolboxes
NTDs
2
Rapid Response
1
HIV
1
Global Health Education
1
Planetary Health
1
NCDs
1
The 2019 edition treating data for 2018 marks sustained international efforts dedicated to reporting on, analysing and understanding the year-to-year variations and long-term trends of a changing cl
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl
...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s eliminatio
...
- Resilient Markets
- Resilient Agriculture
- Resilient People
- Political Leadership for Resilient Growth
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepat
...
The article outlines the prioritized research agenda for the prevention and control of chronic respiratory diseases (CRDs) as part of
...
